Key result
Fetal Ehlers-Danlos syndrome was associated with a significantly increased risk of preterm birth compared to pregnancies with non-EDS infants (31.7% vs 23.7%, RR 1.34).
Why the study?
Most studies have focused on maternal EDS contribution to poor pregnancy outcomes, leaving the relative fetal versus maternal contribution unclear.
Does fetal Ehlers-Danlos syndrome status compared to maternal status increase the risk of poor pregnancy outcomes?
Observational (n=1,704)
Does fetal Ehlers-Danlos syndrome status compared to maternal status increase the risk of poor pregnancy outcomes?
Relative Risk: 1.34 (95% CI 1.06–1.69)
Absolute Event Rate: 31.7% vs 23.7%
p-value: p=0.011
Fetal Ehlers-Danlos syndrome status, rather than maternal status, is significantly associated with increased risks of preterm birth and preterm premature rupture of membranes (PPROM).
Fetal EDS status linked to higher preterm birth and PPROM rates than maternal status; hypothesis-generating and should not yet change practice.
The majority of research papers published on obstetrical outcomes in Ehlers-Danlos syndrome (EDS) have focused on the contribution of maternal EDS to the risk of poor pregnancy outcomes. The purpose of our study was to further clarify the fetal versus maternal contribution of EDS to poor pregnancy outcomes. A web-based, anonymous questionnaire was developed to collect pregnancy histories of families with a member with EDS. The survey was disseminated via social media through the Ehlers Danlos National Foundation. Population descriptors (age, gender, EDS diagnosis, age of diagnosis) and pregnancy descriptors (number of pregnancies, live births, and birth complications) were collected. To identify fetal and maternal contribution of EDS to poor pregnancy outcomes, three groups were compared based on maternal or infant diagnosis (EDS versus non-EDS). The rate of birth complications, treatment for preterm birth, and occurrence of preterm birth, as well as gestational age at preterm birth, were different depending on maternal/ infant EDS status, and these differences were significant when comparing infant EDS status but not when comparing maternal EDS status. The occurrence of PPROM is increased in the non-EDS mother/EDS infant group compared to both EDS mother/non-EDS infant and EDS mother/EDS infant groups (38.9%, 12.5%, 14.8%, p = 0.025). This study identifies that poor outcomes in EDS pregnancies differ depending on the maternal and the fetal EDS status. These insights into maternal and fetal association with certain poor pregnancy outcomes in pregnancies complicated by EDS can further guide physicians in educating, managing, and treating these women during pregnancy.
No takes yet. Share an insight, caveat, or question.
Underhill et al. (2022) conducted an observational in Ehlers-Danlos syndrome (EDS) in pregnancy (n=1,704). Fetal Ehlers-Danlos syndrome (EDS) vs. Infant without EDS was evaluated on Preterm birth (PTB) (RR 1.34, 95% CI 1.06-1.69, p=0.011). Fetal Ehlers-Danlos syndrome was associated with a significantly increased risk of preterm birth compared to pregnancies with non-EDS infants (31.7% vs 23.7%, RR 1.34).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: